Maryland Heights, MO, August 14, 2016 --(PR.com
)-- According to a new market research report published by iHealthcareAnalyst, Inc., Cardiac Prosthetic Devices Market Analysis and Forecast 2013-2020, the global cardiac prosthetic devices market is estimated to reach USD 5.8 Billion in 2020, expanding at a CAGR of 9.4% from 2016 to 2020.
Visit the Cardiac Prosthetic Devices Market Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/cardiac-prosthetic-devices-market/
The global cardiac prosthetic devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
An artificial heart valve is a device implanted in the heart of a patient with valvular heart disease. There are three main types of artificial heart valves: the mechanical, the biological, and the tissue engineered valves. Cardiac pacemaker devices are small, battery-operated devices that senses heart beating irregularities and sends a signal to heart to makes it beat at the adequate pace.
The global cardiac prosthetic devices market segmentation is based on device or product types (heart valves, mechanical heart valves, tissue heart valves, stented tissue valve, transcatheter heart valves, pacemaker, implantable pacemaker, single-chamber battery pacemaker, dual-chamber battery pacemaker, triple-chamber battery pacemaker, external pacemaker). The global cardiac prosthetic devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiac prosthetic devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Device/Product Type
1.1. Heart Valves
1.1.1.Mechanical Heart Valves
1.1.2. Tissue Heart Valves
1.1.3. Stented Tissue Valve
1.1.4. Transcatheter Heart Valves
1.2.1. Implantable Pacemaker
1.2.2. Single-Chamber Battery Pacemaker
1.2.3. Dual-Chamber Battery Pacemaker
1.2.4. Triple-Chamber Battery Pacemaker
1.2.5. External Pacemaker
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World
3. Company Profiles
3.1. Abbott Laboratories
3.2. Abiomed, Inc.
3.3. AtriCure, Inc.
3.4. Boston Scientific Corporation
3.5. Edward Lifesciences Corporation
3.6. Medtronic, Inc.
3.7. Siemens Healthcare
3.8. Sorin Group
3.9. St. Jude Medical, Inc.
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043